RUA Life Sciences plc (FRA:AOHA)

Germany · Delayed Price · Currency is EUR

0.3160

+0.0200 (6.76%)

Last updated: Oct 12, 2026, 9:48 PM CET

Market Cap	23.51M +186.6%
Revenue (ttm)	5.29M +3.5%
Net Income	322.58K
EPS	0.01
Shares Out	n/a
PE Ratio	68.26
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	550
Open	0.3100
Previous Close	0.2960
Day's Range	0.3100 - 0.3160
52-Week Range	0.0870 - 0.3480
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 11, 2026

About RUA Life Sciences

RUA Life Sciences plc, together with its subsidiaries, develops medical devices in Europe, North America, the Middle East, the Asia Pacific, and Africa. It operates through four segments: Biomaterials, Contract Manufacture, Vascular, and Structural Heart. The company acts as the depository of intellectual property and licensing rights to various biostable and implantable polymers, including Elast-Eon and ECSil; and provides sub-contract manufacturing, assembly, packing, and services of medical device, as well as implantable fabric. It also enga... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1996

Employees 59

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol AOHA

Financial Performance

Financial numbers in GBP Financial Statements